Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Shocking tinnitus away: new brain retraining trial offers hope

NCT ID NCT07393880

Symptom relief Sponsor: University of Dublin, Trinity College Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new way to treat chronic tinnitus by pairing gentle electrical stimulation on the back of the head with a listening exercise. One hundred adults with constant ringing in the ears will be randomly assigned to receive real or fake stimulation combined with active or passive listening. The goal is to see if this approach can lower the perceived loudness and emotional impact of tinnitus over six months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2026

Expected to finish

Jan 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18-80 years * Continuous subjective tinnitus for \>3 months and ≤5 years * Predominantly tonal tinnitus (unilateral or bilateral) * Screening THI score 28-76 * Minimum Masking Level (MML) 20-80 dB HL * No prior tinnitus neuromodulation treatment * Able to comply with eight sessions over four weeks and follow-up assessments Exclusion Criteria: * Objective tinnitus or predominantly somatic tinnitus * Pulsatile tinnitus * Evidence of conductive hearing loss (abnormal otoscopy or tympanometry) * Pure-tone audiometry exclusions: \>40 dB HL at any frequency 250 Hz-1 kHz OR \>80 dB HL at any frequency 2-8 kHz in either ear * Hearing aid use initiated within the past 90 days * Active implantable medical device (e.g., pacemaker, DBS, cochlear implant) * LDL \<30 dB SL at 500 Hz in either ear * Diagnosis of temporomandibular joint disorder or occipital neuralgia * Severe anxiety (STAI \>120/160) * Cognitive impairment (MMSE \<25) * Severe depressive symptoms (BDI ≥30) * Diagnosis of Menière's disease * Current pregnancy * Involvement in medicolegal cases * History of auditory hallucinations * Current prescription of central nervous system drugs likely to alter neuromodulatory function (e.g., noradrenergic, dopaminergic, serotonergic, benzodiazepine, cholinergic, or other psychoactive medications) * Currently enrolled in another interventional study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic tinnitus are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

tinnitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic tinnitus Tinnitus Tinnitus, subjective

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Trinity College Institute of Neuroscience (TCIN)

    RECRUITING

    Dublin, Dublin, D02, Ireland

More trials for these conditions

Other studies related to the condition(s) this trial covers.